Fampridine in MS Patients: A Cognition, Fatigue, Depression and Quality of Life Analysis
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 09 Aug 2018
At a glance
- Drugs Fampridine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms FAMILY
- Sponsors Genesis Pharma
- 31 Jul 2018 Planned End Date changed from 7 Mar 2018 to 30 Nov 2018.
- 31 Jul 2018 Planned primary completion date changed from 7 Mar 2018 to 30 Nov 2018.
- 31 Jul 2018 Status changed from recruiting to active, no longer recruiting.